Associated Papers
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study.
Zhang H et al.
Oncology Letters, 2021
33692861 (PubMed )
Supplement: Supplementary_Data.pdf
Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells.
Gimenez-Xavier P et al.
Oncotarget, 2018
30140389 (PubMed )
Supplement: oncotarget-09-31549-s003.xlsx › Sheet1
Select a paper to view details